Nestlé puts €18m on table for epigenetics research

By Annie Harrison-Dunn contact

- Last updated on GMT

Nestlé invests big in epigenetics, the study of how environmental factors including eating behaviours may alter genetics
Nestlé invests big in epigenetics, the study of how environmental factors including eating behaviours may alter genetics

Related tags: Nutrition, Nestlé

Nestlé is to contribute 22m Swiss francs (€18.31m) to a 6-year multinational epigenetics research partnership.

The company has been collaborating with the EpiGen Consortium – a public-private partnership made up of institutions from Southampton, Auckland and Singapore – since 2011. Nestlé’s contributing scientists work from its research centre in Lausanne, Switzerland.

pregnancy_fruit_vegetables

The company said it hoped epigenetics, the study of how environmental factors including eating behaviours could impact genetics of the consumer and therefore future generations, would help it understand more about the importance of maternal nutrition. 

Chief technology officer for the firm Stefan Catsicas said it was particularly interested in the areas of pregnancy-related conditions such as gestational diabetes.

Heiko Schipper, CEO of Nestlé Nutrition, said: “Science shows that the nutrition infants and young children receive in the first 1000 days from conception has a long-lasting influence on their health, wellness and quality of life.”

University of Southampton’s Keith Godfrey, head of the EpiGen science management group, said the project would study mothers and infants from three distinct populations, which he said would provide further insight into the, “relationship between genetic background and nutritional influences on disease burden for the mother and infant”.​ 

Established in 2006, EpiGen research have taken an epigenetic look at issues such as the impact of size at birth on risk of disease later in life. 

One study​, published in 2011, looked at maternal nutrition during pregnancy, such as a low-carb diet, and chemical changes to the baby’s DNA. 

Related news

Show more

Related products

show more

Business case: private label iron supplements

Business case: private label iron supplements

PharmaLinea Ltd. | 18-May-2021 | Case Study

A line of clinically supported private label iron supplements by PharmaLinea is selling nearly 500.000 units/year in a market of under 20 million people.

SLENDACOR® Weight Management Complex

SLENDACOR® Weight Management Complex

PLT Health Solutions | 13-Apr-2021 | Product Brochure

For many of us, maintaining a healthy weight can be tedious and difficult. We could all use a little positive reinforcement along our journey. Slendacor...

Pycnogenol® Improves Fitness and Muscle Recovery

Pycnogenol® Improves Fitness and Muscle Recovery

Horphag Research | 28-Sep-2020 | Technical / White Paper

Published studies show daily supplementation of Pycnogenol® is effective in boosting muscle performance, increasing endurance and reducing cramping and...

Related suppliers

Follow us

Products

View more

Webinars